Select The Right Bayesian Optimized Interval (BOIN) Design For Your Oncology Study
Source: Worldwide Clinical Trials

Produce effective, reliable results in Phase 1 oncology trials with Bayesian Optimized Interval (BOIN) designs. These designs enable you to determine the maximum tolerated dose (MTD) or the optimal biological dose (OBD) with ease. With a superior performance compared to rules-based designs, the codified BOIN design is preferred by trials that need an uncommon toxicity threshold, more than 3 dose escalation levels, and flexibility to cohort size and backfilling. Discover which BOIN design best suits your trial needs.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more